Patents by Inventor Robert S. Lee
Robert S. Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11961952Abstract: A secondary battery is provided for cycling between a charged and a discharged state, the secondary battery including a battery enclosure, an electrode assembly, carrier ions, a non-aqueous liquid electrolyte within the battery enclosure, and a set of electrode constraints. The set of electrode constraints includes a primary constraint system having first and second primary growth constraints and at least one primary connecting member, the first and second primary growth constraints separated from each other in the longitudinal direction, wherein the primary constraint array restrains growth of the electrode assembly in the longitudinal direction such that any increase in the Feret diameter of the electrode assembly in the longitudinal direction over 20 consecutive cycles of the secondary battery is less than 20%.Type: GrantFiled: September 6, 2022Date of Patent: April 16, 2024Assignee: Enovix CorporationInventors: Robert S. Busacca, Ashok Lahiri, Murali Ramasubramanian, Bruno A. Valdes, Gardner Cameron Dales, Christopher J. Spindt, Geoffrey Matthew Ho, Harrold J. Rust, III, James D. Wilcox, John F. Varni, Kim Han Lee, Nirav S. Shah, Richard J. Contreras, Lynn Van Erden, Vladimir Dioumaev
-
Publication number: 20240069765Abstract: A system can include a processing device operatively coupled with the one or more memory devices, to perform operations that include writing data to the one or more memory devices and performing one or more scan operations on a management unit containing the data to determine a current value of a chosen data state metric. Each scan operation can be performed using a corresponding predetermined read-time parameter value. The operations can include determining whether the current value of the chosen data state metric satisfies a criterion, and can also include, responsive to determining that the current value of the chosen data state metric satisfies the criterion, selecting a remedial operation by determining whether redundancy metadata is included in a fault tolerant data stripe on the one or more memory devices. The operations can also include performing the remedial operation with respect to the management unit.Type: ApplicationFiled: August 24, 2022Publication date: February 29, 2024Inventors: Kishore Kumar Muchherla, Robert Loren O. Ursua, Sead Zildzic, Eric N. Lee, Jonathan S. Parry, Lakshmi Kalpana K. Vakati, Jeffrey S. McNeil
-
Patent number: 8408136Abstract: A missile, a method of making a missile, and a clamp for making a missile, comprising providing two sections of a missile and joining the two sections with a clamp comprising a plurality of pieces for engaging a circumference of the two sections, each of the pieces comprising at least two grooves extending substantially the length of the piece, and at least two Nitinol rings placed one in each of the at least two grooves.Type: GrantFiled: April 10, 2008Date of Patent: April 2, 2013Assignee: Lockheed Martin CorporationInventor: Robert S. Lee
-
Patent number: 8151203Abstract: A target audience for a marketing campaign is selected using a graphical user interface. A first graphical representation of a customer data attribute is dragged from a first window and dropped in a second window. A second graphical representation of a customer data attribute is dragged near the graphical representation of an initial profile that is created in the second window in response to the dropping of the first graphical representation. The second graphical representation is dropped in an action area presented when the second graphical representation is dragged near the graphical representation of the initial profile.Type: GrantFiled: September 4, 2007Date of Patent: April 3, 2012Assignee: SAP AGInventors: Bernhard M. Runge, Adam Korman, Robert S. Lee
-
Patent number: 7807384Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: GrantFiled: June 12, 2008Date of Patent: October 5, 2010Assignee: Boston Heart Foundation, Inc.Inventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Publication number: 20100028327Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: ApplicationFiled: June 12, 2008Publication date: February 4, 2010Inventors: ANN M. LEES, ROBERT S. LEES, SIMON W. LAW, ANIBAL A. ARJONA
-
Patent number: 7402395Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: GrantFiled: September 24, 2003Date of Patent: July 22, 2008Assignee: Boston Heart Foundation, Inc.Inventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Patent number: 7244410Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: GrantFiled: July 9, 2003Date of Patent: July 17, 2007Assignee: Boston Heart Foundation, Inc.Inventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Patent number: 6878817Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: GrantFiled: October 12, 2001Date of Patent: April 12, 2005Assignee: Boston Heart Foundation, Inc.Inventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Patent number: 6868386Abstract: A method and system for communicating insurance related services between an insured and an insurer through an Internet communication scheme includes a processing system for processing acquired event and sensored data to compute the cost of insurance for the same period as the data is acquired. An enhanced Internet communication scheme provides an insured access to the acquired data and its processing through enhanced presentation systems (e.g., maps with usage, service or special event processing or even automobile service diagnostics.) In addition, communication packages can provide estimates based upon user-supplied information identifying projected usages.Type: GrantFiled: May 15, 2000Date of Patent: March 15, 2005Assignee: Progressive Casualty Insurance CompanyInventors: Maria Henderson, Robert J. McMillan, Alexander D. Craig, John P. Heinen, Byron J. Olexa, Mark C. McElroy, Robert S. Lee
-
Publication number: 20040040049Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: ApplicationFiled: September 24, 2003Publication date: February 26, 2004Applicant: Boston Heart Foundation, Inc., a Massachusetts corporationInventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Publication number: 20040013668Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: ApplicationFiled: July 9, 2003Publication date: January 22, 2004Applicant: Boston Heart Foundation, Inc., a Massachusetts corporationInventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Patent number: 6632923Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: GrantFiled: July 14, 2000Date of Patent: October 14, 2003Assignee: Boston Heart Foundation, Inc.Inventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Patent number: 6605588Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: GrantFiled: March 2, 2000Date of Patent: August 12, 2003Assignee: Boston Heart Foundation, Inc.Inventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Publication number: 20020194633Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: ApplicationFiled: October 12, 2001Publication date: December 19, 2002Applicant: Boston Heart Foundation, Inc., a Massachusetts corporationInventors: Ann M. Lee, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Publication number: 20020152485Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: ApplicationFiled: December 17, 2001Publication date: October 17, 2002Applicant: Boston Heart Foundation, Inc., a Massachusetts corporationInventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Publication number: 20020129388Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: ApplicationFiled: December 17, 2001Publication date: September 12, 2002Applicant: Boston Heart Foundation, Inc., Massachusetts corporationInventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Publication number: 20020052033Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: ApplicationFiled: September 24, 2001Publication date: May 2, 2002Applicant: Boston Heart Foundation, Inc., a Massachusetts corporationInventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Patent number: 6355451Abstract: Isolated polynucleotides encoding novel polypeptides which are capable of binding to native and methylated LDL (low density lipoprotein), the isolated polypeptides, called LBPs (LDL binding proteins), and biologically active fragments and analogs thereof, are described. Also described are methods for determining if an animal is at risk for atherosclerosis, methods for evaluating an agent for use in treating atherosclerosis, methods for treating atherosclerosis, and methods for treating a cell having an abnormality in structure or metabolism of LBP. Pharmaceutical compositions and vaccine compositions are also provided.Type: GrantFiled: November 26, 1997Date of Patent: March 12, 2002Assignee: Boston Heart Foundation, Inc.Inventors: Ann M. Lees, Robert S. Lees, Simon W. Law, Anibal A. Arjona
-
Patent number: 6017510Abstract: This invention relates to radiolabeled peptides and methods for producing such peptides. Specifically, the invention relates to technetium-99m (Tc-99m) labeled leukocyte-binding peptides, methods and kits for making such peptides, and methods for using such peptides to image sites of infection and inflammation in a mammalian body.Type: GrantFiled: June 27, 1994Date of Patent: January 25, 2000Assignee: Diatide, Inc.Inventors: Richard T. Dean, Robert S. Lees, Scott Buttram